4263 — SUSMED Cashflow Statement
0.000.00%
Annual cashflow statement for SUSMED, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -233 | -49.5 | -356 | -297 | -379 |
| Depreciation | |||||
| Non-Cash Items | 6.22 | 12.3 | 20.7 | 50.5 | 141 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 59.6 | 132 | 98.8 | -194 | -246 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -165 | 101 | -231 | -432 | -474 |
| Capital Expenditures | -12.6 | -18.2 | -9.28 | -20 | -156 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -7.75 | — | 0.749 | -0.001 | -71.8 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -20.4 | -18.2 | -8.53 | -20 | -228 |
| Financing Cash Flow Items | -18.9 | 0.8 | -0.001 | -0.331 | -0.327 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 3,463 | 62.4 | 37.4 | 3.67 | 2.75 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,277 | 145 | -202 | -449 | -700 |